Patients with metastatic pancreatic cancer who received the experimental drug elraglusib alongside standard chemotherapy saw ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

The authors sought to understand the differential impact of payer-led community-based care management approaches on stakeholder-oriented outcomes for publicly insured adults with multiple chronic ...

We are testing three nitrogen rates, 0, 50, and 100 kg/ha. In a greenhouse, this is straightforward: identical pots, controlled irrigation, steady temperatures. We randomly assign rates, measure ...

When they are available, randomized controlled trials (RCTs) are the gold standard to evaluate the comparative efficacy and safety of medical interventions 1. Randomization ensures that the ...

Decision analysis of PD-1 inhibitor combined with chemotherapy in neoadjuvant therapy of resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC). This is an ASCO Meeting Abstract ...

The analysis of covariance (Ancova) is a widely used statistical technique for the comparison of groups with respect to a quantitative dependent variable in such a way that the comparison takes into ...

This study explored different risk matrix designs on user comprehension and use of matrices. I’ve posted a lot of research dunking on risk matrices (RMs), so here’s another olive leaf focusing on ...

The hospital’s physical environment can impact health and well-being. Patients spend most of their time in their hospital rooms. However, little experimental evidence supports specific physical design ...

Evidence-based practices for reducing opioid-related overdose deaths include overdose education and naloxone distribution, the use of medications for the treatment of opioid use disorder, and ...

Amivantamab plus lazertinib vs osimertinib in first-line EGFR-mutant advanced non-small cell lung cancer (NSCLC) with biomarkers of high-risk disease: A secondary analysis from the phase 3 MARIPOSA ...

Antibody-mediated rejection is a leading cause of kidney-transplant failure. The targeting of CD38 to inhibit graft injury caused by alloantibodies and natural killer (NK) cells may be a therapeutic ...